Dr. Amy Kang has been appointed to the Board of Pharmacy Specialties’ (BPS) Infectious Diseases Pharmacy Specialty Council. Her appointment to this council will span a three year term (2025-2027), during which time she will provide recommendations on national Infectious Diseases Pharmacy Specialty certification and recertification standards and developing examination content. “Being appointed to this committee
The Chapman University student chapter of the American College of Clinical Pharmacy (ACCP) has been honored as the 2024 Outstanding Chapter Award recipient. This national recognition is annually awarded to a single chapter across the United States for exemplifying dedication to patient care, leadership, and exceptional professional development through membership and organizational activities. Left: CUSP’s
Chapman University’s Dr. Jerika Lam and CSHP‘s CEO Dr. Loriann De Martini co-published “A mixed methods evaluation of pharmacists’ readiness to provide long-acting injectable HIV pre-exposure prophylaxis in California” in the Journal of Acquired Immune Deficiency Syndromes (JAIDS). The study investigated the underlying causes for why HIV prevention medication, pre-exposure prophylaxis (PrEP), isn’t widely used
Dr. Ajay Sharma has received a grant from the National Eye Institute for his project, “Targeting the multicellular process of corneal regeneration and vascularization to enhance outcome of cornea transplantation”. He, alongside investigators from the University of Virginia and the Ohio State University, will test the effect of topical application of a recombinant protein Mitsugumin
The Antimicrobial Stewardship Committee at Harbor-UCLA Medical Center has been awarded Gold status by the California Department of Public Health (CDPH), reserved for programs that demonstrate exemplary practices and have impactful community outcomes. Dr. Amy Kang, an Assistant Professor of Pharmacy Practice, secured this award as the co-chair of the committee at Harbor-UCLA Medical Center.
Melinta Theraputics has awarded an Industry Grant to Dr. Gary Fong for his proposal, “Identifying the Need and Potential Role for a Novel Long-Acting Antifungal in a Diverse, Underserved Population“ , totaling $19,836. Dr. Fong will be working alongside his Co-Principal Investigator Dr. Scott Filler, Professor of Medicine at David Geffen School of Medicine at
Dr. Jason Yamaki and Dr. Sherif Elshahawi have been honored with the 2024 CUSP Collaboration Award for their innovative research proposal, “Developing Drug Leads to Inhibit C. difficile Bacterial Infection.” The research aims to open more opportunities for discovering solutions in antibiotic resistance for infectious disease treatments. The CUSP Collaboration Award is designed to foster